Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Government Resource

Medicare’s Oversight of Compounded Pharmaceuticals Used in Hospitals.

Medicare’s Oversight of Compounded Pharmaceuticals Used in Hospitals. Levinson DR. Washington, DC: US Department of Health and Human Services, Office of the Inspector General; January 2015. Report No. OEI-01-13-00400.

Save
Print
February 11, 2015
Levinson DR. Washington, DC: US Department of Health and Human Services, Office of the Inspector General; January 2015. Report No. OEI-01-13-00400.
View more articles from the same authors.

A widely-reported meningitis outbreak in the United States uncovered quality and safety issues associated with the use of compounded sterile preparations. This publication describes an analysis of five accreditation organizations and their ability to provide oversight and inspection of Medicare hospitals that contract with compounding entities. The authors offer recommendations to help hospitals determine if their compounded sterile preparations contracts ensure products are prepared safely for use, including targeted training for surveyors related to compounding and improved contracting processes.

Save
Print
Cite
Citation

Medicare’s Oversight of Compounded Pharmaceuticals Used in Hospitals. Levinson DR. Washington, DC: US Department of Health and Human Services, Office of the Inspector General; January 2015. Report No. OEI-01-13-00400.